Literature DB >> 25760917

Spectrum of Uveitis in A German Tertiary Center: Review of 474 Consecutive Patients.

Rafael S Grajewski1, Albert Caramoy1, Konrad F Frank2, Andrea Rubbert-Roth3, Gerd Fätkenheuer3, Bernd Kirchhof1, Claus Cursiefen1, Ludwig M Heindl1.   

Abstract

PURPOSE: To analyze the spectrum of uveitis at a German tertiary center. PATIENTS AND METHODS: A total of 474 consecutive patients with uveitis were classified according to the primary anatomic site of inflammation, examined for laterality of disease, and screened for etiologies.
RESULTS: Out of the total, 253 patients (53%) had anterior uveitis, 90 patients (19%) had intermediate uveitis, 100 patients (21%) had posterior uveitis, and 31 patients (7%) had panuveitis. Fifty-six percent of the patients had bilateral involvement, predominantly in intermediate uveitis (ratio 4:1) and panuveitis (ratio 3.4:1). Regarding the etiology of all uveitis cases we found 17% infectious, 23% specific clinical entities, 20% associated with systemic disease (most commonly sarcoidosis with 11%), and 41% idiopathic uveitis.
CONCLUSIONS: Anterior uveitis was the most common anatomic site of intraocular inflammation. Using a tailored approach, screening for systemic etiologies is recommended, since 20% of all patients had associated systemic diseases.

Entities:  

Keywords:  Clinical characteristics; epidemiology; etiology; uveitis

Year:  2015        PMID: 25760917     DOI: 10.3109/09273948.2014.1002567

Source DB:  PubMed          Journal:  Ocul Immunol Inflamm        ISSN: 0927-3948            Impact factor:   3.070


  20 in total

1.  Spectral-domain optical coherence tomography findings of the macula in 500 consecutive patients with uveitis.

Authors:  R S Grajewski; A C Boelke; W Adler; S Meyer; A Caramoy; B Kirchhof; C Cursiefen; L M Heindl
Journal:  Eye (Lond)       Date:  2016-07-08       Impact factor: 3.775

2.  Do systemic steroids increase the risk of ocular complication in uveitis patients? Focus on a Italian referral center.

Authors:  Chiara Posarelli; Rosaria Talarico; Giovanna Vella; Andrea Passani; Marta Mosca; Michele Figus
Journal:  Clin Rheumatol       Date:  2019-06-06       Impact factor: 2.980

Review 3.  Ocular sarcoidosis: new diagnostic modalities and treatment.

Authors:  Sung J Yang; Sherveen Salek; James T Rosenbaum
Journal:  Curr Opin Pulm Med       Date:  2017-09       Impact factor: 3.155

Review 4.  [Sarcoidosis and uveitis : An update].

Authors:  J G Garweg
Journal:  Ophthalmologe       Date:  2017-06       Impact factor: 1.059

Review 5.  [Ocular sarcoidosis].

Authors:  C Springer-Wanner; T Brauns
Journal:  Z Rheumatol       Date:  2017-06       Impact factor: 1.372

6.  Diagnostic and therapeutic evaluation of multiple choroidal granulomas in a patient with confirmed sarcoidosis using enhanced depth imaging optical coherence tomography.

Authors:  Mami Ishihara; Etsuko Shibuya; Shin Tanaka; Nobuhisa Mizuki
Journal:  Int Ophthalmol       Date:  2017-10-05       Impact factor: 2.031

Review 7.  New Immunosuppressive Therapies in Uveitis Treatment.

Authors:  Salvador Mérida; Elena Palacios; Amparo Navea; Francisco Bosch-Morell
Journal:  Int J Mol Sci       Date:  2015-08-11       Impact factor: 5.923

8.  Intermediate uveitis: pattern of etiology, complications, treatment and outcome in a tertiary academic center.

Authors:  Thomas Ness; Daniel Boehringer; Sonja Heinzelmann
Journal:  Orphanet J Rare Dis       Date:  2017-04-27       Impact factor: 4.123

9.  Changes in patterns of uveitis at a tertiary referral center in Northern Italy: analysis of 990 consecutive cases.

Authors:  Cimino Luca; Aldigeri Raffaella; Marchi Sylvia; Mastrofilippo Valentina; Viscogliosi Fabiana; Coassin Marco; Soldani Annamaria; Savoldi Luisa; De Fanti Alessandro; Belloni Lucia; Zerbini Alessandro; Parmeggiani Maria; Chersich Matthew; Soriano Alessandra; Salvarani Carlo; Fontana Luigi
Journal:  Int Ophthalmol       Date:  2017-01-09       Impact factor: 2.031

10.  Intermediate Uveitis Etiology, Complications, Treatment, and Outcomes in a Colombian Uveitis Referral Center.

Authors:  William Rojas-Carabali; Juliana Reyes-Guanes; Valeria Villabona-Martinez; Maria Alejandra Fonseca-Mora; Alejandra de-la-Torre
Journal:  Clin Ophthalmol       Date:  2021-06-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.